Artikel ; Online: Activation of AMPK improves lipopolysaccharide-induced dysfunction of the blood-brain barrier in mice.
2015 Band 29, Heft 6, Seite(n) 777–784
Abstract: Primary objective: Lipopolysaccharide (LPS) is known to alter the integrity of the blood-brain barrier (BBB) in sepsis, although the underlying mechanism remains unknown. The aim of this study was to elucidate the molecular mechanisms underlying ... ...
Abstract | Primary objective: Lipopolysaccharide (LPS) is known to alter the integrity of the blood-brain barrier (BBB) in sepsis, although the underlying mechanism remains unknown. The aim of this study was to elucidate the molecular mechanisms underlying disruption of the BBB in LPS-induced sepsis. Research design: Both in vitro and in vivo experiments were designed to test the role of AMP-activated protein kinase (AMPK) in LPS-induced BBB dysfunction. Methods and procedures: Human brain microvascular endothelial cells (HBMECs) were cultured. The protein expressions were detected by western blot. BBB integrity was determined by Evans Blue. Main outcomes and results: LPS (1 μg ml(-1)) dramatically increased the permeability of the BBB and the ROS productions, as well as reducing the expression levels of occludin and claudin-5 in cultured HBMECs. Inhibition of NAD(P)H oxidase by apocynin or up-regulation of AMPK reversed the LPS-induced abnormities in HBMECs. In LPS-induced sepsis in mice, it was found that LPS dramatically increased NAD(P)H oxidase protein expressions and ROS productions in the brain and disrupted BBB function assayed by Evans blue staining, which were abolished by AICAR treatment. Conclusions: It is concluded that AMPK activation improves the functions of the BBB impaired by LPS through suppression of NAD(P)H oxidase-derived ROS in mice. |
---|---|
Mesh-Begriff(e) | AMP-Activated Protein Kinases/metabolism ; Animals ; Blood-Brain Barrier/drug effects ; Blood-Brain Barrier/metabolism ; Brain/blood supply ; Brain/metabolism ; Cell Membrane Permeability/drug effects ; Cells, Cultured ; Endothelial Cells/drug effects ; Endothelial Cells/enzymology ; Humans ; Lipopolysaccharides/pharmacology ; Male ; Mice ; NADPH Oxidases/metabolism ; Reactive Oxygen Species/metabolism ; Sepsis/chemically induced ; Sepsis/metabolism ; Sepsis/pathology ; Tight Junction Proteins |
Chemische Substanzen | Lipopolysaccharides ; Reactive Oxygen Species ; Tight Junction Proteins ; NADPH Oxidases (EC 1.6.3.-) ; AMP-Activated Protein Kinases (EC 2.7.11.31) |
Sprache | Englisch |
Erscheinungsdatum | 2015-03-20 |
Erscheinungsland | England |
Dokumenttyp | Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't ; Retracted Publication |
ZDB-ID | 639115-1 |
ISSN | 1362-301X ; 0269-9052 |
ISSN (online) | 1362-301X |
ISSN | 0269-9052 |
DOI | 10.3109/02699052.2015.1004746 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 2242: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.